about
Variants of the PPARD gene and their clinicopathological significance in colorectal cancer.MTDH genetic variants in colorectal cancer patients.Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity.The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women.Germline mutation in the TP53 gene in uveal melanoma.The Role of HNF1B in Tumorigenesis of Solid Tumours: a Review of Current KnowledgeSynchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 casesScreening for inherited mutations in the Czech high risk breast cancer patients – analysis of 400 familiesExpression, Epigenetic and Genetic Changes of HNF1B in Endometrial LesionsExpression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitusLymphoepithelioma-like carcinoma of the endometrium: Case report of a rare tumour with comprehensive immunohistochemical and molecular analysisComparison of five different scoring methods in the evaluation of inflammatory infiltration (tumor-infiltrating lymphocytes) in superficial spreading and nodular melanomaA comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variantsStathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesionsIdentification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues
P50
Q35082686-BE42B736-700B-4375-891B-02CCB59A4375Q36694223-2356D4A3-FFCB-43A1-8298-98056E915CA6Q43638942-5612D4CD-33F7-48A9-80CA-5F3BE8A8611DQ46087551-D6CFB3F8-983F-47C5-82CD-1C7572ED1591Q52871118-0BDE67CB-2B39-4C84-92E8-C61DFCC1A987Q53174846-1AD57217-2FDE-4CFD-85A5-ADB8FE080C53Q53831563-840CDEAA-946A-4049-8546-948B771BE7F6Q58579569-B266A3FD-77DA-42E4-BA6A-04ACC7C15EC6Q61456296-5FDF5180-89BD-46FC-9727-24EBB296CA1CQ61896420-49BC378A-3832-469C-9DA2-DF76DCB19CACQ61896451-73AA63B1-81AC-4544-B541-8AC6C384A207Q63438331-58357B41-686E-4DAD-96E8-E270BB43E2A2Q89079399-F50C9131-7236-4C5D-8521-DFF77E5B306CQ90155012-FA5003B3-5C37-49A0-88C4-22CF07B0E520Q91344892-1B6DA0C3-0FB4-4319-B067-CF64E285B67FQ93034188-5C9244D1-3B9F-42DD-8C02-2AEBDF886775Q93216612-0CFE130C-DB21-4D06-9EF8-2957C0BD6B8A
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ivana Ticha
@ast
Ivana Ticha
@es
Ivana Ticha
@nl
Ivana Ticha
@sl
Ivana Tichá
@cs
Ivana Tichá
@en
type
label
Ivana Ticha
@ast
Ivana Ticha
@es
Ivana Ticha
@nl
Ivana Ticha
@sl
Ivana Tichá
@cs
Ivana Tichá
@en
altLabel
Ivana Tichá
@en
Ticha I
@en
Tichá I
@en
Tichá Ivana
@en
prefLabel
Ivana Ticha
@ast
Ivana Ticha
@es
Ivana Ticha
@nl
Ivana Ticha
@sl
Ivana Tichá
@cs
Ivana Tichá
@en
P1053
D-7033-2017
P106
P1153
36877711700
P21
P214
49153833256664332715
P31
P3829
P496
0000-0002-8451-4222
P691
P7859
viaf-49153833256664332715